Genomic Health, Inc.

Redwood City,  CA 
United States
  • Booth: 6166, 6778

With over 800,000 patients tested worldwide, Genomic Health is the world’s leading provider of genomic-based diagnostic tests. The company’s Oncotype DX Genomic Prostate Score® provides information which, combined with clinical factors, more accurately stratifies risk and helps urologists and their clinically low-risk patients choose more confidently between active surveillance and immediate treatment.

Brands: Oncotype DX Genomic Prostate Score®, Oncotype DX® AR-V7 Nucleus Detect(TM) Assay